COVID-19 Impact on The Coca-Cola Company, H2 2020 Update

COVID-19 Impact on The Coca-Cola Company, H2 2020 Update



"COVID-19 Impact on The Coca-Cola Company, H2 2020 Update" reports key findings as of October 5, 2020 based on market analysis and brand diversification by industry and geography.

The coronavirus outbreak has had an adverse impact on the companys sales across all regions, leading to a significant decline in its Q2 2020 revenue. Coca-Cola is undertaking initiatives to keep up with changing consumer habits and tap into the recent pandemic-fueled online sales of beverages and food. The non-alcoholic beverage giant is also taking necessary measures to help its employees, customers, and various stakeholders in the face of the pandemic. COVID-19 has negatively impacted Coca-Cola so far and will continue to do so for the rest of the year because of its lack of product diversity.

Scope

- Revenues in North America were the most affected in Q2 2020 primarily because of the effect of COVID-19 in the US.
- Coca-Colas soft drinks sales are expected to be heavily impacted by the pandemic.
- A significant decline is projected in Coca-Colas non-alcoholic beverage brand sales due to weak demand for soft drinks during the crisis, particularly in its North American market.
- Losses in the sales of carbonates are expected to lead to a massive decline in non-alcoholic beverage sales in 2020.

Reasons to Buy

- Understand the challenges and opportunities faced by a specific company in order to tap into what is really impacting the industry.
- Gain a broader appreciation of the fast-moving consumer goods industry by gaining insights from both within and outside of your sector.
- Access valuable strategic take-outs to help direct future decision-making and inform new product development.


COVID-19 impact analysis on Coca Cola key findings as of October 5, 2020
Geographic spread analysis COVID-19 vs Coca Cola brand sales
The impact of COVID-19 on Coca Cola regional sectors
Coca Cola 2020 exposure - brand sales at risk by region and Sector
Contact Us


Restaurant Experiences Post-COVID-19 - Dining Out is likely to be Reviewed, Refreshed, or Completely Re-Imagined after the Pandemic - Foodservice Insights and Trends

Restaurant Experiences Post-COVID-19 - Dining Out is likely to be Reviewed, Refreshed, or Completely Re-Imagined after the Pandemic - Foodservice Insights and TrendsThe post-pandemic dining experience will undergo a significant

USD 1950 View Report

Global Peptide Therapeutics Market (2021 Edition) – Analysis By Drug Type (Generic, Innovative), Manufacturing Type (In-House, Outsourced), Application,, By Region, By Country: Market Insights, Covid-19 Impact, Competition and Forecast (2021-2026)

Executive The Global Peptide Therapeutics Market is valued at USD 32.1 Billion in the year 2020. The growth of Peptide Therapeutics is directly associated with drug development. New drug discovery

USD 2400 View Report

Coronavirus Disease 2019 (COVID-19) Impact on Clinical Trials, 2021 Update

Coronavirus Disease 2019 (COVID-19) Impact on Clinical Trials, 2021 UpdateThis 62-page PowerPoint based report gives an important update to the previous year with an expert analysis on how COVID-19 is

USD 1495 View Report

Global Peptide Therapeutics Market (2021 Edition) – Analysis By Drug Type (Generic, Innovative), Manufacturing Type (In-House, Outsourced), Application,, By Region, By Country: Market Insights, Covid-19 Impact, Competition and Forecast (2021-2026)

Executive The Global Peptide Therapeutics Market is valued at USD 32.1 Billion in the year 2020. The growth of Peptide Therapeutics is directly associated with drug development. New drug discovery

USD 2400 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available